Discover how OTU-family de-ubiquitylating enzymes lost their catalytic activity through evolution, becoming molecular zombies with new cellular functions.
Explore how failures in the ubiquitin-proteasome system contribute to Parkinson's disease pathology and potential therapeutic approaches.
Discover how targeting the p97 protein could revolutionize cancer treatment by eliminating cancer stem cells and overcoming treatment resistance.
Discover how thyroid hormones activate the ubiquitin-proteasome system to regulate cardiac hypertrophy and maintain heart health through protein quality control.
Discover how first-in-class molecular glue degraders target AR-V7 in treatment-resistant prostate cancer, offering new hope for patients.
Explore how diabetes research is translating cellular mechanisms into effective clinical treatments, from SGLT2 inhibitors to personalized medicine approaches.
Explore how the discovery of Parkin's crystal structure is revolutionizing our understanding and treatment of Parkinson's disease.
Discover how SETBP1 mutations disrupt protein degradation in atypical chronic myeloid leukemia, driving cancer progression through impaired ubiquitination.
Discover how inhibiting miR-23b-3p could transform keloid treatment by restoring A20 function and normalizing fibroblast behavior.
Discover how single-cell RNA sequencing is revealing the genetic diversity within chordoma tumors and paving the way for targeted cancer therapies.